Article info

Download PDFPDF

Selective estrogen receptor modulators contribute to prostate cancer treatment by regulating the tumor immune microenvironment

Authors

  1. Correspondence to Dr Dali Tong; tongdali1985{at}163.com
View Full Text

Citation

Tong D
Selective estrogen receptor modulators contribute to prostate cancer treatment by regulating the tumor immune microenvironment

Publication history

  • Accepted February 27, 2022
  • First published April 5, 2022.
Online issue publication 
April 05, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.